You are here

Xospata

Astellas Xospata comes up short again in bid to expand leukemia use

Fierce Pharma

Thu, 03/9/23 - 09:13 pm

clinical trials

Astellas maintains lead over Daiichi Sankyo with CHMP okay for Xospata

Pharmaforum

Sun, 09/22/19 - 11:02 pm

AACR: Astellas pads Xospata's AML lead with chemo-beating survival data

Fierce Pharma

Mon, 04/1/19 - 12:38 pm

acute myeloid leukemia

FDA stamps fast OK on Astellas' pioneering FLT3 AML drug gilteritinib, expanding on a record year for new approvals

Endpoints

Thu, 11/29/18 - 12:10 am